Photo of Leonard Tuanquin
Contact Expert

View Scopus Profile

Leonard Tuanquin, MD

    • 3 Citations
    • 1 h-Index
    20092019
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

    • 4 Similar Profiles
    Neurofibromin 2 Medicine & Life Sciences
    Molecular Targeted Therapy Medicine & Life Sciences
    Combined Modality Therapy Medicine & Life Sciences
    Hodgkin Disease Medicine & Life Sciences
    Kidney Neoplasms Medicine & Life Sciences
    Chemoradiotherapy Medicine & Life Sciences
    Renal Cell Carcinoma Medicine & Life Sciences
    Suicide Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output 2009 2019

    • 3 Citations
    • 1 h-Index
    • 2 Article
    • 1 Comment/debate

    Suicide among cancer patients

    Zaorsky, N., Zhang, Y., Tuanquin, L., Bluethmann, S., Park, H. S. & Chinchilli, V., Dec 1 2019, In : Nature communications. 10, 1, 207.

    Research output: Contribution to journal › Article

    Suicide
    cancer
    Epidemiology
    Neoplasms
    lungs
    3 Citations (Scopus)

    Targeted Therapy in Collecting Duct Carcinoma of the Kidney: A Case Report and Literature Review

    Yin, M., Wang, W., Rosenberg, J., Kaag, M. G., Joshi, M., Holder, S., Tuanquin, L. & Drabick, J., Apr 1 2016, In : Clinical Genitourinary Cancer. 14, 2, p. e203-e206

    Research output: Contribution to journal › Article

    Neurofibromin 2
    Molecular Targeted Therapy
    Combined Modality Therapy
    Kidney Neoplasms
    Chemoradiotherapy

    Relapsed or refractory hodgkin lymphoma: Dilemmas in balancing the risks and benefits of therapeutic modalities

    Tuanquin, L. & McGarry, R. C., Jul 2009, In : American Journal of Hematology/ Oncology. 8, 7

    Research output: Contribution to journal › Comment/debate

    Hodgkin Disease
    Therapeutics